Developing a rapid detection system for MDR in cancer.

Ongoing project involves the design and manufacturing of a microfluidics based lab-on-a-chip kit design and an analysis device for early cancer diagnosis. The product will be used to detect cross-resistance to chemotherapeutic drugs, therefore will decrease the treatment period and increase the success of treatment significantly.

Client: Mikro Biyosistemler Inc.     Team: Nur Yildirim (ID), Hakan Gürsu, Dr (CDO)     Place: Designnobis     Year: 2017

NDAed project is carried in collaboration with Mikrobiyosistemler AS, a biomedical microsystems company spinoff from METU and it is partially funded by EU Pre-Accession Funding Programme.